Showing results (81-90 of 679) with videos related to
Sort By:
Pageof 68
Revue Medicale De Liege|May 10, 2000
[Antioxidant vitamins in the prevention of cardiovascular diseases. First part: epidemiologic studies]A J ScheenRevue Medicale De Liege|May 8, 2001
[Pharmacy clinics. Medication of the month. Clopidogrel (Plavix)]A J ScheenDiabetes & Metabolism|February 2, 2019
Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complicationsA J ScheenRevue Medicale De Liege|December 30, 2004
[Withdrawal of rofecoxib (Vioxx): what about cardiovascular safety of COX-2 selective non-steroidal anti-inflammatory drugs?]A J ScheenRevue Medicale De Liege|March 1, 2013
[Limited add-on value of oral glucose-lowering agents in type 1 diabetes]A J ScheenRevue Medicale De Liege|December 8, 2015
[EMPAGLIFLOZIN (JARDIANCE) :Nw SGLT2 COTRANSPORTER INHIBITOR FOR TREATING TYPE 2 DIABETES]A J ScheenRevue Medicale De Liege|June 3, 2021
[Environment and cancer : not easy to dissect the exposome !]A J ScheenDiabetes & Metabolism|January 18, 2006
Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion?A J ScheenRevue Medicale De Liege|April 7, 2017
[Dapagliflozin (forxiga®) : SGLT 2 cotransporter inhibitor as glucose-lowering agent in type 2 diabetes]A J ScheenPageof 68